SCA Pharmaceuticals has voluntarily recalled 73,312 containers of Oxytocin (30 units added to 0.9% Sodium Chloride, 500 mL) because tests showed the medication was subpotent, meaning it did not meet the required strength standards. This prescription drug is used in healthcare settings as an injection to induce or improve labor. No incidents or injuries have been reported to date in connection with this recall.
A medication with low potency may not provide the intended therapeutic effect, which could potentially delay or complicate clinical procedures during labor or delivery where oxytocin is medically necessary.
Distributed to hospitals and healthcare facilities nationwide.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.